Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia

Abstract

Aims Iron deficiency is frequently observed in patients with acute coronary syndrome and associates with poor prognosis after acute myocardial infarction (AMI). Anaemia is linked to dysregulation of iron metabolism, red blood cell dysfunction, and increased reactive oxygen species generation. Iron supplementation in chronic heart failure is safe and improves cardiac exercise capacity. Increases in iron during ischaemia or immediately after reperfusion are associated with detrimental effects on left ventricular (LV) function. The safety and applicability of iron during or immediately after reperfusion of AMI in anaemia are not known. We aimed to study the safety and efficacy of iron supplementation within 1 h or deferred to 24 h after reperfusion of AMI by analysing LV function and infarct size. Methods and results In a mouse model of moderate blood loss anaemia (n = 6–8 mice/group), the effects of iron supplementation (20 mg iron as ferric carboxymaltose per kg body weight) within 1 h and deferred to 24 h after ischaemia/reperfusion were assessed. Cardiac function was analysed in vivo by echocardiography at baseline (Day 3) with and without anaemia, after AMI (24 h), and after administration of intravenous iron. Anaemia was characterized by iron deficiency and a trend towards increased haemolysis, which was supported by increased plasma free‐haemoglobin [sham vs. anaemia (n = 8/group): P < 0.05]. Anaemia increased heart rate, LV end‐diastolic volume, stroke volume, and cardiac output, while LV end‐systolic volume remained unchanged at baseline. Superimposition of AMI deteriorated global LV function, whereas infarct sizes remained unaffected [sham vs. anaemia (n = 6/group): P = 0.9]. Deferred iron supplementation 24 h after ischaemia/reperfusion resulted in reversal of end‐systolic volume increase and reduced infarct size [% of area at risk: sham vs. anaemia + iron after 24 h; (n = 6/group); 48 ± 7 vs. 38 ± 7; P < 0.05], whereas administration within 1 h after reperfusion was neutral [sham vs. anaemia + iron; (n = 6/group); 48 ± 7 vs. 42 ± 8; P = 0.56]. Moreover, iron application after reperfused AMI showed unaltered mortality compared with sham. Conclusions Iron supplementation 24 h after reperfusion of AMI is safe and reversed enlargement of end‐systolic volume after AMI resulting in increased stroke volume and cardiac output. This highlights its potential as adjunctive treatment in anaemia with ID after reperfused AMI. Time point of iron application after reperfusion appears critical.

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles

“…Most FDA-approved inorganic NPs are iron oxide NPs for iron replacement treatments. As representative examples, Ferinject ® is in the market as colloidal NPs consisting of a polynuclear iron (III)-(oxyhydroxide) core stabilized by carboxymaltose and proposed for the treatment of anemia (Wischmann et al, 2021), Feraheme ® are polymer coated supermagnetic iron oxide NPs formulated with mannitol indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Metallic NPs are widely explored for early detection, thermotherapy, and biomarker identification for the treatment of cancer.…”

Ferrokinetic Evaluation of Patients With Acute Coronary Syndrome at a South American Hospital, Pilot Study

“…Iron is an essential element for life, since it participates in practically all oxidation-reduction processes. We can find it forming an essential part of the enzymes of the Krebs cycle, in cellular respiration and as an electron carrier in cytochromes (1). The maintenance of normal iron metabolism is particularly important for cells that are characterized by a high mitogenic potential and high energy demand (2-3), and its deficiency may be an important comorbidity in high-risk patients (4).…”

Asociación entre la ferrocinética y su papel pronóstico en enfermedad coronaria en un hospital suramericano

“…Iron is an essential element for life since it participates in practically all oxidation-reduction processes. We can find it as a necessary part of the enzymes of the Krebs cycle, in cellular respiration, and as an electron transporter in cytochromes (1).…”